RVTY expands endocrine diagnostics with FDA-cleared testosterone assay
- Posted on May 14, 2026
- By Bing News
- 0 Views
- 1 min read
RVTY expands endocrine diagnostics with FDA-cleared testosterone assay
Revvity, Inc. RVTY recently announced that its subsidiary, Immunodiagnostic Systems (“IDS”), received FDA clearance for its Total Testosterone automated chemiluminescence immunoassay (ChLIA). The assay complements the company’s existing FDA-cleared ChLIA tests for free testosterone and sex hormone-binding globulin (SHBG), creating a comprehensive automated testosterone testing solution on a single platform. Management stated that the addition of...
